A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

2,009

Participants

Timeline

Start Date

Not specified

Study Completion Date

May 31, 2001

Conditions
HIV InfectionsPregnancy
Interventions
DRUG

Nevirapine

Trial Locations (20)

10016

Bellevue Hosp / New York Univ Med Ctr, New York

10032

Columbia Presbyterian Med Ctr, New York

33161

Univ of Miami (Pediatric), Miami

35233

Univ of Alabama at Birmingham - Pediatric, Birmingham

77030

Texas Children's Hosp / Baylor Univ, Houston

191044318

Children's Hosp of Philadelphia, Philadelphia

200102916

Children's Hosp of Washington DC, Washington D.C.

212874933

Johns Hopkins Hosp - Pediatric, Baltimore

277103499

Duke Univ Med Ctr, Durham

381052794

Saint Jude Children's Research Hosp of Memphis, Memphis

606143394

Chicago Children's Memorial Hosp, Chicago

701122699

Tulane Univ / Charity Hosp of New Orleans, New Orleans

900951752

UCLA Med Ctr / Pediatric, Los Angeles

920930672

UCSD Med Ctr / Pediatrics / Clinical Sciences, La Jolla

941430105

UCSF / Moffitt Hosp - Pediatric, San Francisco

981050371

Children's Hospital & Medical Center / Seattle ACTU, Seattle

021155724

Children's Hosp of Boston, Boston

016550001

Univ of Massachusetts Med School, Worcester

071032714

Univ of Medicine & Dentistry of New Jersey / Univ Hosp, Newark

009365067

Univ of Puerto Rico / Univ Children's Hosp AIDS, San Juan

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH